{
  "created_at": "Tue Nov 02 14:46:41 +0000 2021",
  "id_str": "1455538970411028483",
  "full_text": "The maker of a promising drug to treat ALS, or Lou Gehrig’s disease, has submitted an application to the FDA for approval of its use https://t.co/rhcqFsSGLA",
  "display_text_range": [
    0,
    156
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/rhcqFsSGLA",
        "expanded_url": "https://on.wsj.com/3jZUkpt",
        "display_url": "on.wsj.com/3jZUkpt",
        "indices": [
          133,
          156
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 13,
  "favorite_count": 126,
  "possibly_sensitive": false,
  "original_created_at": "Tue Nov 02 14:15:07 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "ALS（ルー・ゲーリック病）の治療薬として期待されている薬のメーカーが、その使用を承認するための申請書をFDAに提出しました。https://t.co/rhcqFsSGLA。"
    },
    {
      "locale": "zh",
      "full_text": "一种治疗ALS（即卢伽雷氏病）的有希望的药物的制造商已经向美国食品和药物管理局提交了一份申请，要求批准其使用https://t.co/rhcqFsSGLA。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "一種治療ALS（即盧伽雷氏病）的有希望的藥物的製造商已經向美國食品和藥物管理局提交了一份申請，要求批准其使用https://t.co/rhcqFsSGLA。"
    }
  ]
}